Richard N. Clayton
#138,258
Most Influential Person Now
Richard N. Clayton's AcademicInfluence.com Rankings
Richard N. Claytonbiology Degrees
Biology
#9616
World Rank
#12840
Historical Rank
Endocrinology
#122
World Rank
#133
Historical Rank
Download Badge
Biology
Why Is Richard N. Clayton Influential?
(Suggest an Edit or Addition)Richard N. Clayton's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Gonadotropin-releasing hormone receptors: characterization, physiological regulation, and relationship to reproductive function. (1981) (520)
- An audit of outcome of treatment in acromegaly. (1993) (493)
- The effect of hypopituitarism on life expectancy. (1996) (469)
- How common are polycystic ovaries in normal women and what is their significance for the fertility of the population? (1992) (359)
- Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production (1979) (350)
- Corticotropin tests for hypothalamic-pituitary- adrenal insufficiency: a metaanalysis. (2008) (340)
- Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. (2004) (328)
- Comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. (1999) (297)
- Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. (2011) (296)
- Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. (1999) (293)
- The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas. (2008) (278)
- Regulation of pituitary receptors for gonadotropin-releasing hormone during the rat estrous cycle. (1980) (240)
- Regulation of peptide hormone receptors and gonadal steroidogenesis. (1980) (230)
- Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism (1996) (223)
- Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles. (1989) (220)
- Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. (1999) (218)
- Cardiovascular function in acromegaly. (2003) (217)
- Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island. (2000) (210)
- Molecular genetic studies of sporadic pituitary tumors. (1994) (208)
- Hyperandrogenism in polycystic ovary syndrome. Evidence of dysregulation of 11 beta-hydroxysteroid dehydrogenase. (1994) (205)
- Absence of gonadotropin-releasing hormone receptors in human gonadal tissue (1982) (199)
- Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. (1997) (196)
- Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors. (1999) (188)
- Radioiodinated nondegradable gonadotropin-releasing hormone analogs: new probes for the investigation of pituitary gonadotropin-releasing hormone receptors. (1979) (185)
- Direct inhibition of testicular function by gonadotropin-releasing hormone: mediation by specific gonadotropin-releasing hormone receptors in interstitial cells. (1980) (177)
- Gonadotrophin-releasing hormone: its actions and receptors. (1989) (165)
- ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. (2009) (153)
- Regulation of pituitary gonadotropin-releasing hormone receptors by gonadal hormones. (1981) (148)
- Association of somatotrophinomas with loss of alleles on chromosome 11 and with gsp mutations. (1993) (148)
- Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study. (2016) (130)
- Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours (1998) (130)
- Characterization of gonadotropin-releasing hormone receptors in cultured rat pituitary cells. (1980) (127)
- Hypermethylation of the p16/CDKN2A/MTS1 gene and loss of protein expression is associated with nonfunctional pituitary adenomas but not somatotrophinomas (1999) (126)
- Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome. (1996) (124)
- Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. (1999) (122)
- Gonadotropin-releasing hormone modulation of its own pituitary receptors: evidence for biphasic regulation. (1982) (117)
- Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities (2001) (114)
- Ovarian gonadotropin-releasing hormone receptors. I. Properties and inhibition of luteal cell function. (1980) (111)
- Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours (1996) (109)
- Receptor-binding affinity of gonadotropin-releasing hormone analogs: analysis by radioligand-receptor assay. (1980) (103)
- Altered composition of high density lipoproteins in women with the polycystic ovary syndrome. (1997) (102)
- Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes. (1997) (99)
- Hypothalamic regulation of pituitary gonadotropin-releasing hormone receptors: effects of hypothalamic lesions and a gonadotropin-releasing hormone antagonist. (1982) (94)
- Preferential loss of Death Associated Protein kinase expression in invasive pituitary tumours is associated with either CpG island methylation or homozygous deletion (2002) (93)
- Molecular Pathogenesis of Pituitary Tumors (2000) (92)
- Loss of expression of the growth inhibitory gene GADD45γ, in human pituitary adenomas, is associated with CpG island methylation (2004) (90)
- Luteinizing hormone-releasing hormone inactivation by purified pituitary plasma membranes: effects of receptor-binding studies. (1979) (88)
- Prevalence of an immunological LH β‐subunit variant in a UK population of healthy women and women with polycystic ovary syndrome (1995) (88)
- A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone. (1999) (88)
- Interaction of fluorescent gonadotropin-releasing hormone with receptors in cultured pituitary cells. (1981) (87)
- Assessment of GH status in adults with GH deficiency using serum growth hormone, serum insulin‐like growth factor‐l and urinary growth hormone excretion (1995) (87)
- Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. (2001) (86)
- p53 Protein accumulates in Cushings adenomas and invasive non-functional adenomas. (1994) (85)
- Insulin sensitivity in women with polycystic ovary syndrome: relationship to hyperandrogenemia. (1994) (81)
- Radiotherapy for non-function pituitary tumours. (1998) (79)
- Assessment of GH status in acromegaly using serum growth hormone, serum insulin‐like growth factor‐I and urinary growth hormone excretion (1995) (79)
- Endothelial dysfunction in endocrine disease (2001) (77)
- Are activating mutations of the adrenocorticotropin receptor involved in adrenal cortical neoplasia? (1995) (75)
- Ovarian gonadotropin-releasing hormone receptors. II. Regulation and effects on ovarian development. (1980) (74)
- Epithelial ovarian cancer: influence of polymorphism at the glutathione S-transferase GSTM1 and GSTT1 loci on p53 expression. (1996) (73)
- Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies. (2015) (71)
- PRKAR1A, one of the Carney complex genes, and its locus (17q22-24) are rarely altered in pituitary tumours outside the Carney complex (2002) (67)
- Medical therapy in patients with acromegaly: predictors of response and comparison of efficacy of dopamine agonists and somatostatin analogues. (2009) (66)
- Rat granulosa cells express the gonadotrophin-releasing hormone gene: evidence from in-situ hybridization histochemistry. (1992) (66)
- Pituitary gonadotropin-releasing hormone receptor regulation in mice. II: Females. (1984) (65)
- Does treatment of acromegaly affect life expectancy (1995) (63)
- Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas. (2012) (61)
- Localisation of a gene causing endocrine neoplasia to a 4 cM region on chromosome 1p35-p36. (1997) (61)
- LH-RH binding to purified pituitary plasma membranes: Absence of adenylate cyclase activation (1978) (60)
- Sequence analysis and transcript expression of the MEN1 gene in sporadic pituitary tumours (1999) (60)
- Peripartum hypopituitarism and lymphocytic hypophysitis. (1995) (58)
- Human adrenocorticotropin-secreting pituitary adenomas show frequent loss of heterozygosity at the glucocorticoid receptor gene locus. (1998) (58)
- The glutathione S-transferases: polymerase chain reaction studies on the frequency of the GSTM1 0 genotype in patients with pituitary adenomas. (1993) (58)
- Epigenetic change in pituitary tumorigenesis. (2003) (57)
- Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas. (2001) (57)
- Hypothalamic regulation of pituitary gonadotropin-releasing hormone receptors: effects of gonadotropin-releasing hormone immunoneutralization. (1982) (56)
- Stimulation of pituitary luteinizing hormone secretion by gonadotropin-releasing hormone is not coupled to beta-luteinizing hormone gene transcription. (1988) (53)
- Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas. (1999) (53)
- Aberrant expression of G(1)/S regulators is a frequent event in sporadic pituitary adenomas. (2001) (53)
- Which hormone tests for the diagnosis of polycystic ovary syndrome? (1992) (53)
- Isolation and characterization of a novel pituitary tumor apoptosis gene. (2004) (53)
- Ontogeny of pituitary GnRH receptors in the rat. (1981) (51)
- Gonadotropin-releasing hormone is required for enhanced luteinizing hormone subunit gene expression in vivo. (1988) (51)
- Gonadotropin-releasing hormone desensitization preferentially inhibits expression of the luteinizing hormone beta-subunit gene in vivo. (1988) (50)
- Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins. (2000) (49)
- How reliable is the short synacthen test for the investigation of the hypothalamic-pituitary-adrenal axis? (1998) (48)
- Mortality in Cushing’s Disease (2010) (47)
- Pituitary surgery for acromegaly (1999) (46)
- Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary Tumors (2008) (46)
- Transfection of an inducible p16/CDKN2A construct mediates reversible growth inhibition and G1 arrest in the AtT20 pituitary tumor cell line. (1999) (44)
- The pituitary tumour epigenome: aberrations and prospects for targeted therapy (2012) (43)
- Clonality of Pituitary Tumours: More Complicated than Initially Envisaged? (2001) (42)
- Gonadotropin-releasing hormone regulates follicle-stimulating hormone beta-subunit gene expression in the male rat. (1989) (42)
- Distinct clonal composition of primary and metastatic adrencorticotrophic hormone‐producing pituitary carcinoma (2001) (41)
- Pituitary tumours: all silent on the epigenetics front. (2009) (41)
- Serum IGF-I levels and growth failure in juvenile chronic arthritis. (1989) (41)
- Which hormone tests for the diagnosis of polycystic ovary syndrome? (1992) (40)
- New developments in the management of acromegaly. Should we achieve absolute biochemical cure? (1997) (40)
- Adenosine 3',5'-monophosphate derivatives increase gonadotropin-releasing hormone receptors in cultured pituitary cells. (1984) (39)
- Sporadic pituitary tumours: from epidemiology to use of databases. (1999) (38)
- Pituitary gonadotropin-releasing hormone receptor regulation in the hypogonadotrophic hypogonadal (hpg) mouse. (1983) (37)
- DRAMATIC AND RAPID SHRINKAGE OF A MASSIVE INVASIVE PROLACTINOMA WITH BROMOCRIPTINE: A CASE REPORT (1985) (37)
- Mechanism of GnRH action in gonadotrophs. (1988) (36)
- Ion microprobe, electron microprobe and cathodoluminescence data for Allende inclusions with emphasis on plagioclase chemistry (1978) (36)
- The interaction of gonadotropin-releasing hormone and estradiol on luteinizing hormone and prolactin gene expression in female hypogonadal (hpg) mice. (1989) (35)
- Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. (2003) (34)
- The role of cumulative growth hormone exposure in determining mortality and morbidity in acromegaly: a single centre study (2016) (34)
- Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk (2004) (34)
- Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis. (2011) (33)
- Epigenomic silencing of the BMP-4 gene in pituitary adenomas: a potential target for epidrug-induced re-expression. (2012) (33)
- Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s Disease (2004) (32)
- GONADOTROPHIN RELEASING HORMONE: FROM PHYSIOLOGY TO PHARMACOLOGY (1987) (32)
- Loss of neuronatin expression is associated with promoter hypermethylation in pituitary adenoma. (2009) (32)
- Pituitary tumour clonality revisited. (2004) (31)
- Pituitary gonadotropin-releasing hormone receptor regulation in mice. I: Males. (1984) (31)
- Gonadotropin binding and Leydig cell activation in the rat testis in vivo. (1982) (31)
- Neuroendocrine studies in hyperprolactinaemic male mice. (1987) (30)
- Tumour suppressor genes in the pathogenesis of human pituitary tumours. (1997) (30)
- Effect of treatment with GnRH antagonist, GnRH antiserum and bromocriptine on pituitary-testicular function of adult rats (1984) (30)
- Molecular Genetics of Pituitary Tumours (1998) (29)
- Castration increases luteinizing hormone subunit messenger RNA levels in male rat pituitaries. (1985) (29)
- A paradigm shift in the monitoring of patients with acromegaly: last available growth hormone may overestimate risk. (2014) (28)
- PULSATILE ADMINISTRATION OF GnRH FOR THE TREATMENT OF HYPOGONADOTROPHIC HYPOGONADISM (1984) (28)
- Is changing hypothalamic activity important for control of ovulation? (1987) (27)
- Clinical and genetic changes in a case of a Cushing's carcinoma (1995) (27)
- Gonadotropin-releasing hormone binding and activation of enriched population of pituitary gonadotrophs (1982) (27)
- Hyperprolactinaemia attenuates the gonadotrophin releasing hormone receptor response to gonadectomy in rats. (1982) (27)
- Evidence for a pituitary site of gonadal steroid stimulation of GnRH receptors in female mice. (1985) (26)
- Regulation of gonadotrophin subunit gene expression. (1993) (25)
- DOES GROWTH HORMONE RELEASING FACTOR DESENSITIZE THE SOMATOTROPH? INTERPRETATION OF RESPONSES OF GROWTH HORMONE DURING AND AFTER 10‐HOUR INFUSION OF GRF 1–29 AMIDE IN MAN (1986) (25)
- Monitoring disease activity using GH and IGF‐I in the follow‐up of 501 patients with acromegaly (2009) (25)
- A RADIOIMMUNOASSAY FOR GnRH AGONIST ANALOGUE IN SERUM OF PATIENTS WITH PROSTATE CANCER TREATED WITH D‐Ser (tBu)6AZA Gly10 GnRH (1985) (25)
- Gonadotrophin releasing hormone receptor regulation in relationship to gonadotrophin secretion. (1985) (25)
- Blockade of rat testicular gonadotropin releasing hormone (GnRH) receptors by infusion of a GnRH antagonist has no major effects on Leydig cell function in vivo (1987) (25)
- Pituitary Tumours: Recommendations for Service Provision and Guidelines for Management of Patients (1998) (24)
- Polymorphism of glycogen synthetase gene in polycystic ovary syndrome (1996) (24)
- Regulation of LH subunit mRNA levels by gonadal hormones in female rats. (1988) (24)
- Pituitary-testicular function in immature rats after treatment with GnRH antagonist, GnRH antiserum and bromocriptine (1984) (23)
- Medroxyprogesterone at high altitude. The effects on blood gases, cerebral regional oxygenation, and acute mountain sickness. (2004) (23)
- Somatostatin partially reverses desensitization of somatotrophs induced by growth hormone-releasing factor. (1987) (22)
- [2] Preparation of radiolabeled neuroendocrine peptides (1983) (22)
- Increased gonadotrophin releasing hormone receptors on pituitary gonadotrophs: effect on subsequent LH secretion (1985) (22)
- Genome‐wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss (2003) (22)
- Methylation mechanisms in pituitary tumorigenesis. (1999) (22)
- Response of acromegaly to long term bromocriptine therapy: a biochemical and clinical assessment. (1978) (21)
- Pituitary tumours. (2001) (20)
- Genomic sequence analysis of a key residue (Arg183) in human Gαq in invasive non‐functional pituitary adenomas (1997) (20)
- Cyclic adenosine nucleotides and growth hormone-releasing factor increase cytosolic growth hormone messenger RNA levels in cultured rat pituitary cells. (1986) (19)
- Short Synacthen test versus insulin stress test for assessment of the hypothalamo [correction of hypothalmo]-pituitary--adrenal axis: controversy revisited. (1996) (19)
- Cardiovascular complications of Cushings syndrome: Impact on morbidity and mortality (2022) (19)
- Role of GnRH in the regulation of pituitary GnRH receptors in female mice. (1985) (19)
- Corticotroph Carcinoma Presenting as a Silent Corticotroph Adenoma (2004) (19)
- Endogenous inhibitors of 11β–hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome (2000) (18)
- Pituitary and gonadal function in hypogonadotrophic hypogonadal (hpg) mice bearing hypothalamic implants. (1985) (18)
- GSTM1 and CYP2D6 genotype frequencies in patients with pituitary tumours: effects on P53, ras and gsp. (1995) (18)
- Gonadal regulation of pituitary hormone mRNA levels in male rats. (1988) (17)
- Gonadotropin-releasing hormone agonist analog-induced steroidogenic lesion in the neonatal rat testis: evidence for direct gonadal action. (1984) (17)
- Pituitary gonadotrophin-releasing hormone receptor up-regulation in vitro: dependence on calcium and microtubule function. (1985) (16)
- Mortality in cushing's disease: stoke-on-trent data and meta-analysis (2011) (16)
- P53 protein accumulates in Cushings adenomas and invasive non-functional adenomas. (1995) (16)
- Expression of luteinising hormone-β subunit chloramphenicol acetyltransferase (LH-β-CAT) fusion gene in rat pituitary cells: Induction by cyclic 3′-adenosine monophosphate (cAMP) (1991) (15)
- Newborn and immature rat testes contain gonadotropin-releasing hormone (GnRH) receptors, and their testosterone production is stimulated by a GnRH agonist in vitro (1985) (15)
- Cycle abnormalities in infertile women with regular menstrual cycles: effects of clomiphene citrate treatment. (1994) (15)
- Solubilized active pituitary and ovarian gonadotropin-releasing hormone receptors retain binding properties for adenosine 3',5'-cyclic monophosphate derivatives. (1984) (15)
- Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells (2015) (15)
- Preincubation of pituitary tumor cells with the epidrugs zebularine and trichostatin A are permissive for retinoic acid-augmented expression of the BMP-4 and D2R genes. (2013) (15)
- Role of prolactin in the regulation of sensitivity of the hypothalamic-pituitary system to steroid feedback. (1987) (14)
- Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults (2001) (14)
- Bromocriptine and Dopamine Mediate Independent and Synergistic Apoptotic Pathways in Pituitary Cells (2010) (13)
- Effects of castration or testosterone implants upon pituitary function in hypogonadal mice bearing normal foetal preoptic area grafts. (1987) (13)
- Regulation of LH subunit and prolactin mRNA by gonadal hormones in mice. (1989) (13)
- Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (Zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer (2004) (12)
- Comparison of the pretranslational regulation of FSH synthesis by gonadal steroids in rats and mice. (1990) (12)
- The EFEMP1 Gene: A Frequent Target for Epigenetic Silencing in Multiple Human Pituitary Adenoma Subtypes (2013) (12)
- EFFECT OF BROMOCRIPTINE ON LH PULSATILITY IN THE POLYCYSTIC OVARY SYNDROME (1987) (12)
- Hypopituitarism and atherosclerosis (2001) (12)
- Monument Draw and the formation of the Acapulcoites (1992) (11)
- Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis (2004) (11)
- Effects of the gonadotrophin-releasing hormone agonist 'Zoladex' upon pituitary and gonadal function in hypogonadal (hpg) male mice: a comparison with normal male and testicular feminized (tfm) mice. (1992) (11)
- Hypothalamic GnRH and pituitary gonadotroph relationships during rat fetal life. (2009) (11)
- Mortality, cardiovascular events and risk factors in hypopituitarism. (1998) (11)
- Pituitary tumours are multiclonal from the outset: evidence from a case with dural metastases (2002) (11)
- Bioactivity of growth hormone releasing hormone (1–29) analogues after SC injection in man (1989) (11)
- Effect of testosterone on gonadotrophin-releasing hormone receptors in the castrated rat: preliminary evidence for a stimulatory effect of testosterone on gonadotrophin function in the male rat. (1986) (10)
- Oncogenesis and Molecular Biology of Pituitary Tumors (1996) (10)
- Advances in Brief Loss of pRb Expression in Pituitary Adenomas Is Associated with Methylation of the RB 1 CpG Island 1 (2000) (10)
- THE HEAT CAPACITIES OF THE CRYSTALLINE AND VACUUM DEHYDRATED FORM OF MAGNESIUM SULPHATE MONOHYDRATE (1957) (10)
- Dissociation between pituitary GnRH binding sites and LH response to GnRH in vitro (1986) (10)
- Pituitary receptors for LH-releasing hormone (LHRH) and responsiveness to LHRH in adult female rats after neonatal monosodium L-glutamate treatment. (1985) (10)
- Do polycystic ovaries on ultrasound scan indicate decreased insulin sensitivity in sisters of women with polycystic ovary syndrome? (2005) (9)
- Homologous ligand regulation of gonadotrophin-releasing hormone receptors in vivo: relationship to gonadotrophin secretion and gonadal steroids. (1985) (9)
- Tumour suppressor genes in pituitary tumour formation. (1999) (9)
- Homologous ligand induction of pituitary gonadotrophin-releasing hormone receptors in vivo is protein synthesis dependent (1984) (8)
- Oxygen Isotopic Anomalies in an Ordinary Chondrite (1980) (8)
- Pituitary tumours: recommendations for service provision and guidelines for management of patients. Royal College of Physicians. (1998) (8)
- Molecular biology of human pituitary adenomas. (1998) (8)
- EFFECT OF INJECTION SITE ON THE PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED LUTEINIZING HORMONE RELEASING HORMONE (1986) (7)
- Silicon Isotope Systematics During Distillation (1987) (7)
- Dopamine agonist- and antagonist-induced modulation of pituitary gonadotrophin releasing hormone receptors are independent of changes in serum prolactin. (1984) (7)
- Gonadotrophin receptors. (1996) (6)
- Secondary hypoadrenallrm with hypercalcaemia (1994) (6)
- The low-dose synacthen test for the assessment of secondary adrenal insufficiency (2000) (6)
- Does an Increase in the Sensitivity of Serum Thyrotropin Assays Reduce Diagnostic Costs for Thyroid Disease in the Community? (1997) (6)
- Response to Dr. Oelkers: There Is Enough Evidence in Favor of Low Dose ACTH Test—Authors’ Response1 (1999) (5)
- The role of pituitary gonadotrophin-releasing hormone receptors in the physiological regulation of gonadotrophin secretion. (1983) (5)
- Primary colorectal tumors fail to express the proapoptotic mediator PTAG and its reexpression augments drug‐induced apoptosis (2007) (5)
- Analysis of Cyclin D 1 ( CCND 1 ) Allelic Imbalance and Overexpression in Sporadic Human Pituitary Tumors 1 (1999) (5)
- 10 Hypothalamic releasing-hormone receptors (1983) (4)
- POLYCYSTIC OVARIES ARE INHERITED AS AN AUTOSOMAL DOMINANT TRAIT: ANALYSIS OF 29 PCO AND 10 CONTROL FAMILIES (1999) (4)
- Evidence for the use of igf-I as a predictor of mortality in acromegaly is lacking. (2004) (4)
- Effect of oestrogen treatment on gonadotroph function in adult male rats. (1987) (4)
- Role of GnRH in the maturation of pituitary gonadotroph function. (1985) (4)
- The role of AIP in familial acromegaly (2007) (4)
- Obesity and PCOS (2009) (4)
- Physiological role of putative testicular gonadotrophin releasing hormone (GnRH). (1986) (3)
- Spontaneous pregnancy after trans‐sphenoidal surgery in a patient with lymphocytic hypophysitis (2007) (3)
- Luteinizing hormone releasing hormone degrading activity associated with a purified pituitary plasma membrane fraction [proceedings]. (1977) (3)
- Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome. (2000) (3)
- [Ontogenesis of the hypothalamo-hypophyseal system. Partial autonomy of the development of the fetal adenohypophysis in the rat]. (1987) (3)
- Pharmacological regulation of pituitary LHRH receptors (1984) (3)
- Pituitary GnRH Receptors — Recent Studies and Their Functional Significance (1986) (3)
- Physiological Regulation of Pituitary GnRH Receptors (1984) (2)
- Preparation of radiolabeled neuroendocrine peptides. (1983) (2)
- O-174. Frequency of a variant form of LH in women with PCOS (1997) (2)
- Nitrogen Isotopes in Abee Clasts (1980) (2)
- Polycystic ovary syndrome (1995) (2)
- Caveats in Treating Thyroid Disease: Practical Implications (2006) (2)
- Carbimazole therapy in the setting of end-stage renal disease and haemodialysis. (2006) (2)
- CHROMOSOME-11 ABNORMALITIES IN SOMATOTROPHINOMAS FROM PATIENTS WITH ACROMEGALY (1991) (2)
- Should every patient being assessed for bariatric surgery be screened for Cushing syndrome? (2011) (2)
- Molecular genetics, hypogonadism and luteinizing hormone (1992) (2)
- Excess vascular mortality in hypopituitarism: is it the result of estrogen or GH deficiency? (2002) (2)
- Short Synacthen Test (Standard and Low dose): Do we need multiple cortisol samples? (2007) (1)
- Androgen metabolism and binding in skin and fibroblasts from a case of incomplete male pseudohermaphroditism [proceedings]. (1977) (1)
- Obesity and Polycystic Ovary Syndrome (2006) (1)
- Chromosome 13 q Deletion Mapping in Pituitary Tumors : Infrequent Loss of the Retinoblastoma Susceptibility Gene ( RB 1 ) Locus Despite Loss of RB 1 Protein Product in Somatotrophinomas 1 (1999) (1)
- The role of the aryl hydrocarbon receptor-interacting protein gene in familial (2008) (1)
- Oxygen Isotopic Studies of Carbonacceous Chondrite Belgica-7904 (1991) (1)
- Caveats in treating thyroid disease: practical implications. (2006) (1)
- Effect of Ovariectomy or Oestrogen Implants upon Pituitary Function in Female Hypogonadal Mice Bearing Normal Fontal Preoptic Area Grafts (1991) (1)
- Allende Inclusions: Cathodoluminescence Petrography: Anorthite and Spinel Chemistry: MG Isotopes (1978) (1)
- Hypothalamic releasing-hormone receptors. (1983) (1)
- Letters to the Editors (1967) (0)
- Medical image. Delayed puberty--an occult systemic cause. (2010) (0)
- Cycle abnormalities in infertile women with regular menstrual cycles: effects of clomiphene citrate**Clomiphene citrate, Marion Merrell Dow Ltd., Uxbridge, United Kingdom. treatment††Supported by the Medical Research Council, London, United Kingdom. (1994) (0)
- Deletions in Invasive and Noninvasive Nonfunctional Pituitary Adenomas : The Deleted Region Involves Markers Outside of the MTS 1 and MTS 2 Genes ' (2006) (0)
- Outcomes in acromegaly: A retrospective study of 419 patients from the West Midlands region of the United Kingdom (2003) (0)
- Genomic sequence analysis of a key residue, within G-alpha-q, in invasive non-functional pituitary adenomas (1997) (0)
- Hormone profile of patients referred for Bariatric surgery (2011) (0)
- Psychosis in a patient with acromegaly: Implications for clinical practice (2007) (0)
- Management of non-functioning pituitary adenomas in a University Hospital: aretrospective analytical audit (2010) (0)
- Madness on the medical ward: ectopic ACTH producing tumour (2014) (0)
- Effect of radiotherapy and pituitary dysfunction on mortality in patients with acromegaly (2008) (0)
- Pituitary tumours: recommendations for service provision and guidelines for management of patients. Committee on Endocrinology of the Royal College of Physicians and the Society for Endocrinology, and the Research Unit of the Royal College of Physicians. (1998) (0)
- Nitrogen Isotopes in the Apollo 16 Deep Drill Core (1982) (0)
- Advances in Reproductive Medicine (1991) (0)
- High resolution allelotyping of adenomas identifies novel regions of genetic loss (2002) (0)
- Editorial (1991) (0)
- Bariatric surgery and Vitamin D deficiency: Pre-operative treatment or post-operative supplementation (2012) (0)
- Subject Index Vol. 92, 2010 (2010) (0)
- Effect of ACTH deficiency and hydrocortisone replacement dose on mortality in patients with acromegaly (2009) (0)
- Persistent hypothyroidism despite optimal therapy: time to rethink (2007) (0)
- Monitoring acromegaly disease activity with growth hormone and insulin like growth factor-I in 501 patients (2008) (0)
- Is mortality in Cushing's disease reversible with remission? (2016) (0)
- Short title: Analysis of the pituitary adenoma methylome (2012) (0)
- Studies of pituitary tumors. (2010) (0)
- ENETS Newsletter Winter 2009/2010 (2010) (0)
- Editorial (2010) (0)
- The clinical and genetic characteristics of patients with familial isolated pituitary adenoma (2009) (0)
- Authors' reply (1992) (0)
- Fundamentals of Clinical Endocrinology (1992) (0)
- Significance of cumulative GH exposure in patients with acromegaly: comparison between patients in whom control was achieved and patients with active disease (2016) (0)
- Factors associated with response to medical therapy in patients with Acromegaly (2008) (0)
- Effect of Hypophysectomy and Growth Hormone Replacement on Hypothalamic Growth Hormone‐Releasing Factor Messenger Ribonucleic Acid Levels (1991) (0)
- Small solar thermal electric power plants with early commercial potential (1979) (0)
- Subject Index Vol. 47, 1997 (1997) (0)
- Title Page / Table of Contents / Preface (2010) (0)
- Exoticism in Fayetteville (1988) (0)
- [Gonadotropin-releasing hormone and its clinical use]. (1981) (0)
- The molecular biology of the ovary and testis. (1988) (0)
- Identification of novel epigenetically silenced sequences in pituitary tumours (2002) (0)
- Editorial (1991) (0)
- Pituitary Tumors, Clonality (2004) (0)
- Endocrine-Related Cancer ( 2003 ) 10 323 – 330 Epigenetic change in pituitary tumorigenesis (2003) (0)
- An audit on management of hyponatraemia in hospitalised patients (2013) (0)
- Spontaneous pregnancy after trans-spenoidal surgery in a patient with pituitary hypophysitis a case report (2006) (0)
- Hypothalamic Gnrh Pulse Generator Activity During Normal Ovulatory Menstrual Cycles (1985) (0)
- Nitrogen and Samarium Isotopes in Ancient Lunar Microbreccias (1980) (0)
- Contents, Vol. 47, 1997 (1997) (0)
- Measurement of Gonadotrophin-Releasing Hormone Receptors: An Index of Hypothalamic Function? (1981) (0)
- The UK pituitary register Collecting data for acromegaly (1999) (0)
- Supplementary Material for: The EFEMP1 Gene: A Frequent Target for Epigenetic Silencing in Multiple Human Pituitary Adenoma Subtypes (2017) (0)
- Predictors of response to medical therapy in patients with acromegaly (2008) (0)
- The importance of achieving disease control in Acromegaly: a retrospective single centre analysis (2018) (0)
- Annual Progress in Reproductive Medicine (1993) (0)
- NON-FUNCTIONING PITUITARY TUMOURS (2002) (0)
- An Ion Microprobe Study of Mg Isotopes in Two Allende Inclusions (1978) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Richard N. Clayton?
Richard N. Clayton is affiliated with the following schools:
